A comparable absence of significant associations between IL-6 expression and clinicopathological parameters—including gender, tumor location, histological subtype, and tumor stage—was also demonstrated by Lu et al., further supporting the heterogeneity of IL-6 involvement in colorectal cancer pathophysiology [31]. Here, IL6 is linked to colorectal cancer.